EyePoint Pharmaceuticals reported a net loss of $34.4 million, or $0.62 per share, in its fourth quarter compared with a net loss of $6.1 million, or $0.16 per share, in the fourth quarter a year ago.
For the full fiscal year, which ended June 30, the company had a net loss of $53.2 million, or $1.15 per share, compared with a net loss of $18.5 million, or $0.52 per share, for the previous year, according to a press release.
Revenues for the quarter were $715,000 compared with $701,000 a year (Read more...)
Uncategorized